A new study conducted by Northwestern University's Feinberg School of Medicine plans to transplant stem cells from a kidney donor's bone marrow into the recipient, in hopes of eventually eliminating the need for anti-rejection drugs.

If successful, post-transplant quality of life for the transplant recipient would be dramatically changed.
 
AAKP will feature more information on this topic in an upcoming issue of aakpRENALIFE. aakpRENALIFE is an AAKP membership benefit and features educational information for patients, dietary guidelines, AAKP news and information on government issues affecting patients. 

This article originally appeared in the February 2008 issue of Kidney Transplant Today.